Managing risk in healthy subjects participating in clinical research

Clinical Pharmacology and Therapeutics

Volumn 74, Issue 6, 2003, Pages 511-512

  Stein, C Michael ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PHARMACOLOGY; CLINICAL RESEARCH; HUMAN; MEDICAL DECISION MAKING; MONITORING; NORMAL HUMAN; NOTE; PRIORITY JOURNAL; RESPONSIBILITY; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SAFETY;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CLINICAL TRIALS; ETHICS COMMITTEES, RESEARCH; HUMAN EXPERIMENTATION; HUMANS; RISK ASSESSMENT;

EID: 0348134959     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2003.08.007     Document Type: Note

References (14)

1. Apseloff G. Severe neutropenia among healthy volunteers given rifabutin in clinical trials. Clin Pharmacol Ther 2003;74:591-2.
2. Flexner C, Barditch-Crovo PA. Severe neutropenia among healthy volunteers given rifabutin in clinical trials. Clin Pharmacol Ther 2003;74:592-3.
3. Death of a volunteer [editorial]. BMJ 1985;290:1369-70.
4. Kolata GB. NIH shaken by death of research volunteer. Science 1980;209:475-9.
5. Day RO, Chalmers DR, Williams KM, Campbell TJ. The death of a healthy volunteer in a human research project: implications for Australian clinical research. Med J Aust 1998;168:449-51.
6. Darragh A, Kenny M, Lambe R, Brick I. Sudden death of a volunteer. Lancet 1985;1:93-4.
7. Ogilvie RI. The death of a volunteer research subject: lessons to be learned. CMAJ 2001;165:1335-7.
8. Institute of Medicine. Responsible research: a systems approach to protecting research participants. October 2002. Available from: URL: http://www.iom.edu/includes/dbfile.asp?id=4157. Accessed July 25, 2003.
9. Levine RJ. Institutional review boards: a crisis in confidence. Ann Intern Med 2001;134:161-3.
10. Burman WJ, Reves RR, Cohn DL, Schooley RT. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med 2001;134:152-7.
11. Schechter AN. The crisis in clinical research: endangering the half-century National Institutes of Health Consensus. JAMA 1998;280:1440-2.
12. Vestal RE. The clinical pharmacologist: an endangered species? Clin Pharmacol Ther 1998;64:471-6.
13. Campbell EG, Weissman JS, Moy E, Blumenthal D. Status of clinical research in academic health centers: views from the research leadership. JAMA 2001;286:800-6.
14. Miller FG. Ethical issues in research with healthy volunteers: risk-benefit assessment. Clin Pharmacol Ther 2003;74:513-5.